UPDATE: Bank of America Downgrades MannKind Following Physician Survey
September 06, 2013 at 12:02 PM EDT
In a report published Friday, Bank of America analyst Steve Byrne downgraded the rating on MannKind Corporation (NASDAQ: MNKD ) from Neutral to Underperform, and lowered the price target from $8.00 to $5.00. In the report, Bank of America noted, “We lowered our rating to Underperform and our PO to
